Tiberiu Stan

This work is part of a collaborative effort with #Synaffix, and I look forward to sharing our findings. If you’re attending #OTS, I invite you to visit our poster to learn more about our Validation Lab’s in vitro and in vivo platforms, as well as our new humanized DMD mouse models.

Excited to attend the Oligonucleotide Therapeutics Society (OTS) Annual Meeting in Budapest!

👉Poster P222 on Tuesday, Oct 21:
“Sustained Muscle Function Improvement After a Single In Vivo Dose of Antibody Oligonucleotide Conjugate (AOC) in the mdx Mouse Model for Duchenne Muscular Dystrophy.”

🔬 Research Technician Human Genetics

Are you seeking a meaningful role where you can apply your expertise to advance the treatment of Duchenne muscular dystrophy? We have an opening for research technician position in our group:
www.lumc.nl/en/about-lum...

A second paper from my former post doc lab in Lund has been accepted recently to EJN and I am sharing (again) the first authorship😊
Neurophysiological treatment effects of mesdopetam, pimavanserin and amantadine in a rodent model of levodopa-induced dyskinesia
www.authorea.com/users/837293...